Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2005
08/18/2005WO2005074968A2 Medical use of basic peptides
08/18/2005WO2005074964A1 Extracts of houttuynia cordata and rubus coreanus and their composition for preventing and treating allergic diseases
08/18/2005WO2005074955A1 Preparations containing echinacea extracts and thiocyanate
08/18/2005WO2005074953A1 Composition of labdane diterpenes extracted from andrographis paniculata, useful for the treatment of autoimmune diseases, and alzheimer disease by activation of ppr-gamma receptors
08/18/2005WO2005074907A1 Gene expression controlling agent
08/18/2005WO2003072601A8 Method for producing hypoallergenic major birch pollen allergens rbet v 1
08/18/2005WO2003004608A3 Drug metabolizing enzymes
08/18/2005US20050182276 Process for the synthesis and crystalline form of agomelatine
08/18/2005US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same
08/18/2005US20050182130 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/18/2005US20050182094 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens
08/18/2005US20050182093 Novel compounds
08/18/2005US20050182077 8-amino-7-substituted-2,6-dioxo-1,2,3,6-tetrahydro-7H-purines; erectile dysfunction; sexual disorders; psychological disorders; hypotensive agents; restenosis; cardiovascular disorders; antidiabetic agents; vision defects; autoimmune diseases; anticancer agents
08/18/2005US20050182070 Method for the treatment of allergic conditions
08/18/2005US20050182069 For treatment of asthma, allergies, inflammation and anxiety; antihistamines; sedatives; tranquilizing agents; 2[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetamide
08/18/2005US20050182057 Aryl N-cyanoguanidines and methods related thereto
08/18/2005US20050182040 Benzamide derivatives
08/18/2005US20050182035 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease, cancer, skin disorders, immune system disorders, asthma, hypertension, hypothyroidism, hypocalcemia, female infertility and alopecia
08/18/2005US20050182034 Method of locking 1alpha-OH of vitamin D compounds in axial orientation
08/18/2005US20050182017 Immunostimulatory nucleic acid molecules
08/18/2005US20050182001 Having immunomodulatory activity; for therapy and prophylaxis of infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus
08/18/2005US20050181985 Coupling proteins to a modified polysaccharide
08/18/2005US20050181501 Anti-TECK antibodies and methods of use therefor
08/18/2005US20050181457 Mixture comprising immunogllobulin G complex for diagnosis, prevention and treatment of autoimmune and allergic disorders
08/18/2005US20050181448 Biological products
08/18/2005US20050181422 Process for high throughput screening of CpG-based immuno-agonist/antagonist
08/18/2005US20050181076 Compositions and methods for treatment of diabetes
08/18/2005US20050181063 Biologically active agent being encapsulated within microspheres which comprise a polymer which has a molecular weight in excess of 94 kDa and a maximum diameter of 20 mu m; for the intra-nasal administration of vaccines in a single shot vaccination
08/18/2005US20050181054 comprising a water-insoluble and/or water-low soluble substance, a medicament, and an aqueous medium, and having an osmotic pressure of less than 290 mOsm; efficient penetration and high permeability blood at the mucosa
08/18/2005US20050180996 Vaccine composition specific to glyceroaldehyde-3-phosphate dehydrogenase for use as tool in prevention and treatment of coccidiosis; veterinary medicine
08/18/2005US20050180973 TREM-1 splice variant for use in modifying immune responses
08/18/2005US20050180963 Probiotic propionibacterium
08/18/2005US20050180961 Probiotics and oral tolerance
08/18/2005CA2847517A1 Use of alkaline phosphatase for the detoxification of lps present at mucosal barriers
08/18/2005CA2560055A1 Method of inducing or modulating immune response
08/18/2005CA2555296A1 Composition of labdane diterpenes extracted from andrographis paniculata, useful for the treatment of autoimmune diseases, and alzheimer disease by activation of ppr-gamma receptors
08/18/2005CA2553040A1 Modified human four helical bundle polypeptides and their uses
08/17/2005EP1564278A1 Composition containing organic substance having double bond with improved oxidation stability
08/17/2005EP1564219A1 N-terminally monopegylated polypeptides and process for their preparation
08/17/2005EP1564202A1 Novel process for synthesizing and a novel crystal form of agomelatin as well as pharmaceutical preparations containing these
08/17/2005EP1563847A1 Agent eleveting dendritic cell precursor level in blood
08/17/2005EP1563845A1 Remedies for allergic diseases
08/17/2005EP1563834A1 Hollow nanoparticles of protein and drug using the same
08/17/2005EP1563083A2 Use of cytokines secreted by dendritic cells
08/17/2005EP1562985A2 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases
08/17/2005EP1562968A1 Anti-il-6 antibodies, compositions, methods and uses
08/17/2005EP1562944A1 Pyrazoloquinolines with immunomodulating activity
08/17/2005EP1562938A1 Heteroaryl-pyrimidine derivatives as jak inhibitors
08/17/2005EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
08/17/2005EP1562920A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
08/17/2005EP1562632A2 Inducible ligand for alpha1 beta1 integrin and uses
08/17/2005EP1562598A2 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis
08/17/2005EP1562582A1 Cholesterol absorption inhibitors for the treatment of demyelination
08/17/2005EP1562579A1 Therapeutic delivery of carbon monoxide
08/17/2005EP1562571A1 Combination of diamide derivatives and immunosuppressive agents for induction of immune tolerance
08/17/2005EP1436380B1 Composition comprising a lactobacillus strain and uses thereof
08/17/2005EP1377558B1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists
08/17/2005EP1315496B1 The treatment of inflammatory disorders
08/17/2005EP1289951B1 Growth hormone secretagogues
08/17/2005EP1224215B1 NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE
08/17/2005EP1200446B1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS
08/17/2005EP1179984B1 Process for manufacturing a product for enhancing immune response in companion animals using a combination of antioxidants
08/17/2005EP1161250B1 Immunostimulant bacterial membrane fractions in cancer treatment
08/17/2005EP1144385B1 Benzoheterocycles and their use as mek inhibitors
08/17/2005EP1073723B1 Ste20-related protein kinases
08/17/2005EP1023067B9 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
08/17/2005EP0939804B1 NEUTROKINE alpha
08/17/2005EP0732930B1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
08/17/2005CN1656216A Tolerogenic antigen-presenting cells
08/17/2005CN1656215A Process for producing cytotoxic lymphocyte
08/17/2005CN1656122A Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
08/17/2005CN1656116A Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the HPV-16 virus
08/17/2005CN1656113A Sialic combined immunoglobulin like agglutinin inhibitors
08/17/2005CN1656099A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
08/17/2005CN1656098A Fused bicyclic pyrimidine derivatives
08/17/2005CN1656097A Xanthine phosphodiesterase V inhibitor polymorphs
08/17/2005CN1656095A Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
08/17/2005CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders
08/17/2005CN1656093A 3-substituted quinuclidines and their use
08/17/2005CN1656087A Therapeutic ion channel blocking agents and methods of use thereof
08/17/2005CN1656085A Carboxylic acid compounds and drugs containing the compounds as the active ingredient
08/17/2005CN1656084A Hydroxymorpholinone derivative and medicinal use thereof
08/17/2005CN1656082A Protein kinase inhibitors
08/17/2005CN1656079A Pyrazole compounds and pharmaceutical compositions comprising the compound
08/17/2005CN1656078A Aminoindazole derivatives as protein kinase inhibitor
08/17/2005CN1656073A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
08/17/2005CN1655833A Medical devices containing rapamycin analogs
08/17/2005CN1655826A Non-viral gene delivery system
08/17/2005CN1655825A Non-viral gene delivery system
08/17/2005CN1655823A Topically applicable pharmaceutical preparation
08/17/2005CN1655818A Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
08/17/2005CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
08/17/2005CN1655813A Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use
08/17/2005CN1655808A Compositions for treating and/or preventing pollinosis
08/17/2005CN1655801A Method for the protection of endothelial and epithclial cells during chemotherapy
08/17/2005CN1655799A Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
08/17/2005CN1655787A Triple monoamine reuptake inhibitors for the treatment of chronic pain
08/17/2005CN1655783A Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
08/17/2005CN1655782A Ophthalmological use of roflumilast for the treatment of diseases of the eye
08/17/2005CN1655774A Bis-aromatic alkanols
1 ... 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 ... 1172